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Melengestrol Acetate at Greater Doses Than Typically Used for Estrous Synchrony in
Bovine Females Does Not Mimic Endogenous Progesterone in Regulation of Secretion
of Luteinizing Hormone and 170-Estradiol'
F.N. KOJIMA, 5 J.R. CHENAULT, 6 M.E. WEHRMAN, 5 E.G. BERGFELD,S AS. CUPP,5 L.A. WERTH,3' 5 V. MARISCAL, 5

T. SANCHEZ, 4 5' RJ. KITTOK, 5 andJ.E. KINDER 2' 5

Department of Animal Science,5 University of Nebraska-Lincoln, Lincoln, Nebraska 68583-0908
The Upjohn Company,6 Kalamazoo, Michigan 49001
ABSTRACT
Our working hypothesis was that doses of melengestrol acetate (MGA) greater than those typically administered in estrous
synchrony regimens would regulate secretion of LH and 17,-estradiol (E,) as endogenous progesterone (P ) does during the
4
midluteal phase of the estrous cycle. We also hypothesized that endogenous P4 from the CL would interact with MGA to further
decrease the frequency of LH pulses and E,. Cows on Day 5 of their estrous cycle (Day 0 = estrus) were randomly assigned to
an untreated control group (CONT, n = 5) or to one of six MGA treatment groups (n = 5 per group): 1) MGA administered
orally each day via a gelatin capsule at a dose of 0.5 mg MGA/cow with the CL present (0.5CL); 2) 0.5 mg MGA/cow daily in
the absence of CL (0.5NO); 3) 1.0 mg MGA with CL present (1.OCL); 4) 1.0 mg MGA without CL (1.ONO); 5) 1.5 mg MGA
with CL present (1.5CL); 6) 1.5 mg without CL (1.5NO). MGA was administered for 10 days (Day 5 = initiation of treatment).
To regress CL, cows assigned to groups without CL received injections of prostaglandin F, (PGF, ; 25 mg) on Days 6 and 7 of
0
their estrous cycle. All cows were administered PGF,. at the end of the 10-day treatment period. During the treatment period,
daily blood samples were collected to determine concentrations of E,. Serial blood samples were collected at 15-min intervals
for 24 h on Days 8, 11, and 14 to determine pattern of LH secretion. Frequency of LH pulses on Days 8, 11, and 14 was greater
(p < 0.05) in cows without CL (0.5NO, 1.ONO, and 1.5NO) than in cows with CL (0.5CL, 1.OCL, 1.5CL, and CONT). Mean
concentrations of LH were greater (p < 0.05) in cows from the 0.5NO group on Days 8 and 11 and were greater (p < 0.05)
in cows from the 0.5NO, 1.ONO, and 1.5NO groups on Day 14 as compared to cows with CL. Overall mean concentrations of
LH across Days 8, 11, and 14 were greatest (p < 0.05) in cows from the 0.5NO group and were also greater (p < 0.05) in
cows from the 0.5NO, 1.ONO, and 1.5NO groups as compared to cows in the 0.5CL, 1.OCL, 1.5CL, and CONT groups. Mean
concentrations of E2 during the treatment period were greater (p < 0.05) in cows from the 0.5NO group than in cows from
either the 1.ONO or the 1.5NO group; these values were also greater (p < 0.05) in cows of the 0.5NO, 1.ONO, and 1.5NO
groups as compared to cows of the 1.OCL and CONT groups. Therefore, we reject our working hypothesis because doses of
MGA greater than those typically used in estrous synchrony protocols did not suppress LH and E, to the same extent that
endogenous P4 does. In addition, MGA treatment when CL were present did not result in a further suppression of LH pulse
frequency or of E, as compared to the values in control cows with functional CL.

INTRODUCTION
Melengestrol acetate (MGA), an orally active synthetic
progestin, has been utilized to synchronize time of ovulation and time of behavioral estrus in cattle [1-4]. However,
treatment with MGA has often been associated with reduced fertility when cows are inseminated at the synchronized estrus that ensues immediately after termination of
MGA administration [1-6]. The possible factors that may influence conception rates at the synchronized estrus after
use of MGA include an increased size of dominant ovarian
follicle(s) [7, 8] that do not ovulate during the MGA treatment period [7-9]. Associated with the increased size of
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'Published as paper No. 10710, Journal Ser. Nebraska Agr. Res. Div.; Research
supported by appropriated funding, State of Nebraska.
2Correspondence: James E. Kinder, A224j Animal Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583-0908. FAX: (402) 472-6362.
3Current address: Department of Veterinary and Biomedical Sciences, University
of Nebraska-Lincoln, Lincoln, NE 68583-0905.
4Current address: Centro de Ganaderia, Colegio de Postgraduados, Chapingo,
Mexico, C.P. 56230.

455

dominant ovarian follicle(s), increased concentrations of 17f3estradiol (E2 ) in peripheral circulation during and immediately after MGA treatment have also been reported [1013]. A reduction in size and weight of the CL on Day 3 of
the estrous cycle after MGA treatment has also been reported [9].
Few studies have evaluated the influence of MGA on secretory pattern of gonadotropins, particularly LH. In general, the pattern of pulsatile secretion of LH in the bovine
female is modulated by the ovarian steroids E2 and progesterone (P4) [14, 15]. Administration of low doses of P4
(2-3 ng/ml in plasma) to cows in the absence of CL was
reported to result in a greater frequency of LH pulses and
increased concentrations of E2 compared to those of control cows with functional CL [13, 16]. Onset of the preovulatory surge of LH was subsequently shown to be earlier
after removal of P4 treatment in cows receiving a low dose
as compared to those receiving greater doses of P4 (7-10
ng/ml in plasma) [13,16]. Treatment with lower doses of
P4 for a duration sufficient to extend the estrous cycle has
resulted in alterations in patterns of ovarian follicular dy-
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TABLE 1. Frequency of LH pulses during serial blood collections on Days 8, 11, and 14 post estrus.
Frequency of LH pulses/24 ha
Treatmentb

n

Day 8

Day 11

Day 14

0.5CL
0.5NO

5
5

5.0 d
16.6 C

4.4e
18.0 c

3 .4d
17.6C

1.OCL

5

3.4

3.6e

1.0NO
1.5CL
1.5NO
CONT
Pooled SEM

4
4
4
4

16.8
7.8

d

d

C

13.0
6.0d
1.3

3 .6 d

Overall
mean
4 .3d
17.4C
d

3.5

1 .3 8 de
5.8
12.8 d

13.0 C

14.5c

7 .3 d

69

4,5

4.5

1.3

1.6

e

13.0

C
d

d

12.9C
5 .0 d

0.8

aDetermined with Pulsar software.
bSee Materials and Methods for definitions of abbreviations and explanation of treatment regimens.
CdeNumbers with differing superscripts within column differ (p < 0.05).

namics and prolonged maintenance of the largest follicle
that was dominant at the time of administration of P4; coincidental increases in concentrations of E2 were also observed [17].

We previously reported [13] that treatment of cows with
MGA in the absence of CL at a dose of 0.5 mg/day, which
is the dose used in estrous synchrony programs, resulted
in frequency of LH pulses and concentrations of E2 in plasma
that were similar to those observed in cows treated with
low doses of P4. Frequency of LH pulses and concentrations
of E2 were greater in cows treated with MGA than in cows
with functional CL that were in the midluteal phase of their
estrous cycle.
Therefore, our working hypothesis was that doses of MGA
greater than those presently used in estrous synchrony programs would regulate frequency of LH pulses and concentrations of E2 in a manner similar to that of endogenous P4
from CL during the midluteal phase of the estrous cycle.
We also hypothesized that endogenous P4 from the CL would
interact with MGA to further decrease the frequency of LH
pulses and peripheral concentrations of E2.
MATERIALS AND METHODS

Experimental Protocol
Thirty-five mature nonlactating beef cows of a composite
breed type (1/4 Hereford, 1/4 Angus, 1/4 Pinzgauer, 1/4
Red Poll) exhibiting normal estrous cycles were used in
this study (3-11 yr of age; 489 ± 12 kg BW, mean + SEM).
Stage of the estrous cycle was synchronized in all cows before initiation of treatments by administration of two injections of prostaglandin F2. (PGF2,,, 25 mg; Lutalyse Sterile
Solution; Upjohn Co., Kalamazoo, MI) 11 days apart. Cows
on Day 5 of their estrous cycle (Day 0 = estrus) were randomly assigned to an untreated control group (CONT, n =
5) or to one of six MGA treatment groups (n = 5/group):
1) MGA (MGA 200 Premix, Upjohn Co.) administered orally
each day via a gelatin capsule at a dose of 0.5 mg MGA/
cow with CL present (0.5CL); 2) 0.5 mg MGA/cow daily
without CL (0.5NO); 3) 1.0 mg MGA with CL present (1.OCL);

4) 1.0 mg MGA without CL (1.ONO); 5) 1.5 mg MGA with
CL present (1.5CL); 6) 1.5 mg without CL (1.5NO). The gelatin capsule was used to ensure that cows received specific
doses of MGA relative to the treatment groups to which
they were assigned. Treatments were initiated on Day 5 of
the estrous cycle and cows received the assigned dosage of
MGA every morning (0800 h) for 10 days. Cows assigned
to the CONT group received an empty gelatin capsule at
the same time. Therefore, cows from the CONT group were
in the luteal phase (from Day 5 to Day 15) of the estrous
cycle during the treatment period. Cows assigned to the
groups without CL received injections of PGF2a (25 mg) on
Days 6 and 7 for regression of the CL to eliminate endogenous P4 from the CL. During the initial estrous synchronization before treatments began, four cows that exhibited
behavioral estrus were assigned to 1.ONO, 1.5CL, 1.5NO, and
CONT groups (one cow per group); however, these cows
did not respond to the injections of PGF2 , 11 days apart at
the initial estrous synchronization before the treatment period as determined by examination of profiles of P4 concentration from Day -3 to Day 50. Data for these cows
were, therefore, eliminated from the statistical analyses.
On Days 8, 11, and 14 after estrus, catheters were inserted in the jugular vein of all cows, and blood samples
were collected at 15-min intervals for 24 h. These blood
samples were used to determine pulse frequency of LH. On
Day 15, simultaneously with the last dose of MGA, all cows
received an injection of 25 mg PGF2a (Hour 0). Blood samples were collected at 3-h intervals beginning at Hour 40
(Day 17) and continuing through Hour 169 (Day 22). These
blood samples were used to determine the interval to preovulatory surges of LH. Blood samples collected at 15-min
and 3-h intervals were allowed to clot at room temperature
and then stored at 4C for 24 h. Samples were then centrifuged at 1520 x g for 15 min, and serum was decanted
and stored at -20°C until assayed for LH.
Daily blood samples were collected in tubes treated with
a 30% solution of EDTA (50 Ixl for a 10-ml blood sample;
Fisher Scientific, Fair Lawn, NJ) from all cows throughout
the treatment period and for 35 days post-treatment (from
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Day -3 to Day 50) in order to evaluate plasma concentrations of P4 and E2 during the treatment period and the estrous cycle following cessation of treatments. In an attempt
to avoid possible degradation of P4 in blood, these samples
were placed on ice immediately and plasma was separated
from blood cells by centrifugation at 1520 x g for 15 min
within 1 h of collection. Plasma was then collected and stored
at -20°C until assayed for P4 and E2. In addition, all cows
were observed for behavioral estrus three times a day at
approximately 0600, 1200, and 1800 h from Day -5 to Day
50.
RAs

Concentrations of LH in all samples collected serially on
Days 8, 11, and 14 were analyzed by RIA [18, 19]. Intra- and
interassay coefficients of variation for LH assays were 2.7
and 10.0%, respectively. Assay sensitivity was 12 pg/ml of
serum. Concentrations of FSH in all pooled serum samples
were analyzed by RIA [19, 20]. Intra- and interassay coefficients of variation for FSH assays were 2.3 and 4.7%, respectively, and assay sensitivity was 56 pg/ml of serum.
Concentrations of P4 in plasma samples collected throughout the experiment were analyzed by RIA [16]. Intra- and
interassay coefficients of variation for P4 assays were 2.3 and
17.6%, respectively; assay sensitivity was 312 pg/ml of plasma.
Concentrations of E2 in plasma samples collected throughout the experiment were also analyzed by RIA [13]. Intraand interassay coefficients of variation for E2 assays were
3.9 and 18.2%, respectively, and assay sensitivity was 0.6 pg/
ml of plasma.
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Data Reduction and StatisticalAnalysis

Mean concentrations of LH (ng/ml) in serum samples,
frequency of pulses of LH (pulses/24 h), and amplitude of
pulses of LH (ng/ml) were determined through the use of
algorithms (Pulsar software modified for the IBM-PC byJ.F.
Gitzen and V.D. Ramirez, Urbana, IL). The G values used
for the Pulsar program were 6.8, 4.4, 1.6, 1.3, and 10.0 for
G(1) through G(5), respectively. Interval to the initiation of
the preovulatory surge of LH was defined as the number
of hours between administration of the last dose of MGA
and/or injection of PGF2,, and the initiation of a continuous
high-amplitude rise in concentrations of LH. Area under the
curve for the profile of P4 during the treatment period (Days
5-15) was determined by measurement with a planimeter.
The length of the estrous cycle following cessation of treatment was determined by examination of profiles for P4 and
E2 concentrations and by observations for behavioral estrus
during this period.
Data on the pulsatile secretion of LH, the concentrations
of P4 and E2 on Days 8, 11, and 14, area under the curve
for the profile of P4, interval to the preovulatory surge of
LH, and length of estrous cycle following cessation of treatment were analyzed as a completely randomized design [21]
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FIG. 1. Secretory profile of LH (15-min intervals for 24 h) from individual representative cows from each treatment group during serial blood
collections on Days 8, 11, and 14 after estrus.
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TABLE 2. Mean concentrations of LH during serial blood collections on Days 8, 11, and 14 post estrus and mean
concentration of FSH during treatment.
Mean concentrations of LH (ng/ml) a
Treatmentb

n

Day 8

0.5CL
0.5NO

5
5

1.03
d
2.60

f

f

Day 11

Day 14

1.00
2. 13d

0.89
2.10d

Overall
mean

Mean FSH
during
treatment
(ng/ml)'

0 .97f
2.2 7 d

1.92
2.07

e

f

f

1.OCL

5

1.11

1.01e

1.02

1.ONO
1.5CL
1.5NO

4
4
4
4

1.62
e
1.27
de
1.64
e
1.080

1.42
f
0.84
e
1 .58 d
ef
1.17

1 .75 d
e

1.10
1.714
0.95e

1.60
1 .0 7ef
1.64
f
1.06

2.13
1.88
1.85
1.97

0.17

0.19

0.18

0.10

0.13

CONT
Pooled SEM

de

0 .9 4e

e

1.83

aDetermined with Pulsar software.
bSee Materials and Methods for definitions of abbreviations and explanation of treatment regimens.
CConcentrations of FSH did not differ among treatment groups or across days of treatment; therefore, data were
pooled.
deNumbers with differing superscripts within column differ (p < 0.05).

by ANOVA using the general linear models procedure of
SAS [22]. Treatment means were compared by orthogonal
contrasts and also Duncan's new multiple range test [21].
Pulse frequencies and mean concentrations of LH across
Days 8, 11, and 14 and concentrations of E2, P4, and FSH
during the treatment period were analyzed through the use
of a mixed model procedure (Proc Mixed) of SAS [23]. The
fitted model included treatment and day as fixed effects and
cow as a random effect. To account for the covariance between observations from the same animal at different days,
different options of covariance structures for residuals
available in the Repeated Statement of Proc Mixed were
considered, and the model with the best fit was chosen to
analyze data. Comparison of means was performed by using Proc Mixed of SAS [23], which employs the t-test and
also Duncan's new multiple range test [21].

in the cows treated with all doses of MGA when CL were
absent (0.5NO, 1.ONO, and 1.5NO) as compared to cows
with CL present (0.5CL, 1.OCL, 1.5CL, and CONT; Table 1).
Frequency of LH pulses did not differ (p > 0.10) among
cows with CL present (0.5CL, 1.OCL, 1.5CL, and CONT). The
number of LH pulses observed during each of the three
serial blood collections was correlated within individual cows
(r = 0.912; Fig. 1). Mean concentrations of LH were greatest
(p < 0.05) in cows from the 0.5NO group on Days 8 and
11; they were greater (p < 0.05) in cows from the 0.5NO,
1.ONO, and 1.5NO groups on Day 14 as compared to MGAtreated cows that had CL and as compared to cows from
the CONT group (Table 2). Overall mean concentrations of
LH across Days 8, 11, and 14 were greatest (p < 0.05) in
cows from the 0.5NO group; they were also greater (p <
0.05) in cows from the 0.5NO, 1.0NO, and 1.5NO groups
as compared to cows of the 0.5CL, 1.OCL, 1.5CL, and CONT
groups (Table 2). Amplitude of LH pulses was not different
(p > 0.10) among cows of all treatment groups on either
Days 8, 11, or 14 (Table 3). Mean concentrations of FSH
during the treatment period did not differ (p > 0.10) among
cows of all treatment groups (Table 2).
On Days 8 and 11, mean concentrations of E2 were greater
(p < 0.05) from the 0.5NO group as compared to the cows

RESULTS

Hormone Concentrationsduring Serial Blood Collection
Periods
During the serial blood collection on Days 8, 11, and 14
after estrus, LH pulses occurred more frequently (p < 0.05)

TABLE 3. Amplitude of LH pulses during serial blood collections on Days 8, 11, and 14 post estrus.
'
Amplitude of LH pulses (ng/ml), b

Treatment'
0.5CL
0.5NO
1.OCL
1.ONO
1.5CL
1.5NO
CONT
Pooled SEM

n
5
5
5
4
4
4
4

Day 8

Day 11

Day 14

1.52
2.16
2.44
1.47
1.52
1.83
1.65
0.50

1.58
2.31
1.63
1.42
1.72
1.89
1.62
0.47

1.28
2.00
1.67
1.55
1.75
2.24
1.67
0.35

aDetermined with Pulsar software.
bAmplitude of LH pulses did not differ among treatment groups on Day 8, 11, or 14 post estrus.
CSee Materials and Methods for definitions of abbreviations and explanation of treatment regimens.
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TABLE 4. Mean concentrations of E2 during serial blood collections on Days 8, 11, and 14 post estrus.
Mean concentrations of E2 (pg/ml)
Treatment a

n

Day 8
d

Day 11

Day 14

3.9'

14.2"b

2 6 .5b

2 2 .7 b

Mean E2
during
treatment
(pg/ml)
6.9"

0.5CL

5

8.4

0.5NO

5

20.8

1.OCL
1.ONO
1.5CL
1.5NO

5
4
4
4

10.3
13.8bC
8.6 d
14.4bC

3.6
12.8Cd
9.5de
17.4C

15.6
12.4"
13.2bC

6.4d
11.1 c
7.0c"
11.0 c

CONT

4

8.3

5.4

5.5

6.5

3.6

1.4

b

d

e

d

2.8

Pooled SEM

de

2.5

6.5c
bc

b

1 8 .4

d

aSee Materials and Methods for definitions of abbreviations and explanation of treatment regimens.
bdNumbers with differing superscripts within column differ (p < 0.05).

with CL present. Mean concentrations of E2 during the treatment period were greater (p < 0.05) in cows from the
0.5NO group than in cows from either the 1.ONO or the
1.5NO group; these values were also greater (p < 0.05) in
cows of 0.5NO 1.ONO, and 1.5NO groups as compared to
cows of 1.OCL and CONT groups (Table 4). Mean concentrations of P4 at the end of treatment (Day 14) were greater
(p < 0.05) in cows from 0.5CL, 1.OCL, 1.5CL, and CONT
groups than cows from the 0.5NO, 1.ONO, and 1.5NO groups
(Table 5). Area under the curve for the profile of P4 during
the treatment period (Days 5-15) was greater (p < 0.05)
in cows from 0.5CL, 1.OCL, and CONT groups compared to
cows of 1.NO and 1.5NO groups, while cows of the 1.5CL
group did not differ from those of the other groups (p >
0.10; Table 5). There was a nonsignificant dose response
among cows treated with MGA in the absence of CL, with
area under the curve for the P4 profile decreasing as dose
of MGA increased (0.5NO, 227.0 + 113; 1.ONO, 134.7 ± 24;
and 1.5NO, 105.1 + 30 arbitrary units). These results indicated that the CL in all cows assigned to the no-CL groups
had regressed as a result of the two injections of PGF2, on
Days 6 and 7. During the treatment period, hormone profiles (E2 and P4) and observations for behavioral estrus indicated that none of these cows exhibited behavioral estrus
or ovulated during treatment.

Interval to the Preovulatory Surge of LH
After cessation of treatments on Day 15, initiation of the
preovulatory surge of LH was earlier (p < 0.05) in cows
from the CONT (90 + 10 h) and 0.5CL (95 ± 10 h) groups
than in cows from the 1.OCL (143 + 9 h) and 1.5CL (158
± 12 h) groups (Table 6). Only one cow from each group
treated with MGA in the absence of CL (0.5NO, 1.ONO, and
1.5NO) had initiated a preovulatory surge of LH within the
169-h blood sampling period after cessation of treatments.
Interestingly, cows exhibiting the preovulatory LH surge that
had received MGA in the absence of CL had intervals much
like those of cows given the same dose of MGA in the presence of CL (Table 6).
Estrous Cycle Following Treatments
Duration of the estrous cycle (number of days between
behavioral estrus) after treatments was shorter (p < 0.05)
in cows from the 1.5NO group compared to cows in other
groups (0.5CL, 0.5NO, 1.OCL, 1.5CL, and CONT; Table 6).
Abnormal function of CL was observed in eleven MGA-treated
cows during the estrous cycle following treatments, and eight
of these eleven cows were from the groups treated with
MGA in the absence of the CL (Table 6). Five cows had a
shortened estrous cycle of less than 14 days (Fig. 2c). One

TABLE 5. Mean concentrations of P4 during serial blood collections on Days 8, 11, and 14 post estrus and area under
the curve for the profile of P4 during the treatment period.
Mean concentrations of P4 (ng/ml)
Treatment a

n

Day 8

Day 11

0.5CL
0.5NO
1.OCL
1.ONO

5
5
5
4

5.00Cd
0.56 e
6.33c
0.63e

5.69
0.61d
6.68c
0.52d

2.83 de

3.70

1.5CL

4

1.5NO
CONT
Pooled SEM

4
4

0.49 e
4.40"d
1.09

Areab
Day 14

(units)

c

6.71C
d
0.44
5.04C
0.38d

681.1cd
227.0 de
808.0'
134.70

cd

4.42c

451.5-'"

022d
7.38 c
1.16

105.1e
762.1
129.3

0.51d
6.36'
1.28

aSee Materials and Methods for definitions of abbreviations and explanation of treatment regimens.
bArea under the curve for concentrations of P4 during treatment period as expressed in arbitrary units.
"CdNumbers with differing superscripts within column differ (p < 0.05).
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TABLE 6. Interval to the preovulatory surge of LH, duration of the estrous cycle and luteal function after cessation
of treatment.
Abnormal P4 profile
following treatment

Treatment

Duration of
the estrous cycle
after cessation
d
of treatment (d)

Interval
to LH
surge (h)b e

a

19.39
17.09
20.09
1 6 .3gh
19.89
1 0 .5h
19.09
2.1

95 9 In = 4)
(85) (n = 1)

0.5CL
0.5NO
1.0CL
1.ONO
1.5CL
1.5NO
CONT
Pooled SEM

143 h

In = 5)

(142) In = 1)
158

h (n

=

3)

(157) (n = 1)
90 9 (n =4)
10

(n = 4)
In = 3)
(n = 5)
(n = 4)
in = 4)
(n = 4)
{n = 4)

Number of cows
with shortened
estrous cyclee

Number of cows
with possible
luteinized
follicle
1
2
0
0
0
2
0

1
1
1
2
0

1
0

'See Materials and Methods for definition of abbreviations and explanation of treatment regimens.
bNumber of cows initiating the preovulatory surge of LH during the 169 h blood collection after cessation of treatment.
lInterval of time from treatment cessation to initiation of the preovulatory surge of LH.
dThe length of the estrous cycle following cessation of treatment was determined by examination of profiles for P4
and E2 concentrations and observations for behavioral estrus during this period.
eCows had a shortened estrous cycle less than 14 days following treatment.
'Cows had a delayed initiation of the estrous cycle for more than 20 days post treatment and had more than 1 ng/
ml of P4 in plasma, indicating the possibility of a luteinized follicle in these animals.
ghNumbers with differing superscripts within column differ (p < 0.05).
'One cow from each treatment group initiated a preovulatory surge of LH during 169 h blood collection.
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cow had reduced concentrations of P4 (2-3 ng/ml) in plasma
with a shortened estrous cycle of less than 14 days. Another
five cows had delayed initiation of luteal function (more
than 20 days post-treatment). These cows had 1-4 ng/ml
of P4 in plasma over an extended period of time after the
cessation of treatment, and profiles of P4 from these cows
were unlike those for the typical estrous cycle (Fig. 2b compared to the control in Fig. 2d). In contrast, profiles of hormones in a typical estrous cycle from an MGA-treated cow
and a control cow are shown in Figure 2, a and d, respectively.
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FIG. 2. Secretory profile of P4 and E2 from individual representative
cows, during and after the treatment period, for (a) a normal estrous cycle
after treatment with MGA (Cow #13; 1.OCL); (b) delayed initiation of the
next estrous cycle with a possible luteinized follicle (Cow #06; 0.5NO); (c)
a shortened estrous cycle, less than 14 days (Cow #27; 1.5NO); and (d) a
normal estrous cycle (Cow #33; CONT).

In the present study, a greater frequency of LH pulses
was observed in cows treated with all doses of MGA in the
absence of CL (0.5NO, 1.ONO, and 1.5NO) during each of
the three serial blood collections (Days 8, 11, and 14). This
greater frequency of LH pulses is characteristic of the pattern of LH pulses normally observed during the follicular
phase of the estrous cycle [24-26]. In addition, mean LH
pulse frequencies pooled across all three serial blood collections in cows among the no-CL groups revealed a nonsignificant dose response trend with LH pulse frequency
+
0.5;
decreasing as dose of MGA increased (0.5NO, 17.4
+
1.0; and 1.5NO, 12.9 ± 0.6 LH pulses/24 h).
1.ONO, 14.5
In contrast, frequency of LH pulses did not differ among
cows treated with doses of MGA in the presence of CL or
among controls (0.5CL, 1.0CL, 1.5CL, and CONT). During
this period, mean concentrations of P4 were greater in cows
from the 0.5CL, 1.OCL, 1.5CL, and CONT groups than in those
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treated with MGA in the absence of the CL (0.5NO, 1.ONO,
and 1.5NO). This is in agreement with the secretory pattern
of LH from previous studies that utilized treatment with either
high or low doses of P4 [13,16] or MGA in the absence of
CL [13].
It has been reported that effects of synthetic progestins
on the pattern of LH pulse frequency were abolished by
the presence of CL [27]. These results indicate that the CL
is the major factor controlling the secretory pattern of LH
during the luteal phase of the estrous cycle. P4 is the major
secretory product of the CL, and MGA failed to modulate
the release of LH in the same manner as a functional CL
secreting P4. Therefore, the doses of MGA used in the present study do not mimic the ability of endogenous P4 to suppress the frequency of the LH pulse. However, all doses of
MGA effectively blocked both the preovulatory surge of LH
and ovulation. From these results, we postulate that MGA
mimics the negative feedback of P4 in blocking the preovulatory surge of LH but not in suppressing pulsatile secretion of LH, although there is a possibility that much higher
doses of MGA might be able to suppress the pulsatile secretion of LH.
On Days 8, 11, and 14, the greatest mean concentrations
of E2 were observed in cows from the 0.5NO group. This
greater E2 probably resulted from greater frequencies of LH
pulses in these cows (20.8:16.6, 26.5:18.0, and 22.7:17.6, pg
of E2/mlLH pulses/24 h, respectively) as compared to cows
of other groups. This is in agreement with results from a
previous study [13] in which concentrations of E2 and frequency of LH pulses were positively correlated. These greater
concentrations of E2 were similar to those observed during
the late follicular phase of the estrous cycle just before the
behavioral estrus and the preovulatory surge of LH [13, 2830]. However, the greater concentrations of E2 did not induce behavioral estrus during the treatment period in the
present study. Therefore, the dose of MGA that blocks behavioral estrus is less than the dose required to suppress
pulsatile secretion of LH to levels observed during the midluteal phase of the estrous cycle. An increase in plasma concentrations of E2 in cows treated with the synthetic progestin in the absence of CL may be the result of less
suppression on the LH pulse frequency, which resulted in
enhanced ovarian follicular development and greater concentrations of E2. Treatment with MGA has been shown to
result in increased size of ovarian follicles [7, 8], estrogenic
capacity [31], and concentrations of E2 in plasma of cows
[11, 12] via less suppression on the frequency of LH pulses
[13].
Use of real-time ultrasonography has indicated that treatment with MGA for a duration sufficient to extend the estrous cycle resulted in the development of ovarian follicles
to larger sizes and in the persistence of dominant follicles
for longer periods than are typical for dominant follicles
during the luteal phase of the estrous cycle [32,33]. These
larger ovarian follicles that develop during progestin-based
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estrous synchrony protocols have been termed "persistent
follicles." The development of persistent ovarian follicles
was first described during treatment with low doses of P4,
in the absence of CL [17], that dramatically altered the pattern of ovarian follicular dynamics. Persistent follicles have
always been associated with greater concentrations of E2 in
the peripheral circulation and a greater frequency of LH
pulses [34]. Interestingly, results from the present study indicated that secretion of FSH may not have a role in the
formation of persistent follicles, at least in cows treated with
MGA. Since the earlier studies, there have been numerous
reports of the development of persistent follicles after treatment with various progestins [34-37]. Previous studies indicated that ovulation of a persistent follicle, brought about
by treatment with either a low dose of P4 [37,38] or norgestomet in the absence of CL [39], resulted in reduced fertility at the synchronized estrus. Therefore, persistent ovarian follicles resulting from treatment with MGA may be a
major factor contributing to reduced fertility rates if cows
are inseminated at the first behavioral estrus that ensues
after the termination of feeding this synthetic progestin.
The timing of the preovulatory surge of LH was earlier
in cows from the CONT and 0.5CL groups than in cows
from the 1.OCL and 1.5CL groups after cessation of treatments. Only one cow from each group treated with MGA
in the absence of CL (0.5NO, 1.ONO, and 1.5NO) had initiated the preovulatory surge of LH within the 169-h blood
sampling period. The intervals to the preovulatory surge of
LH in these cows were very similar to those of cows given
MGA in the presence of the CL. In general, the interval to
the preovulatory surge of LH was prolonged as the dose of
MGA increased. These results indicate that clearance of MGA
may be closely associated with interval to the preovulatory
surge of LH after treatment with MGA. These observations
are explained by the fact that MGA is stored in adipose tissue of the body and released very slowly after the administration of MGA is ended [40].
After treatment ended, the duration of the estrous cycle
was shorter in cows from the 1.5NO group compared to
cows from the 0.5CL, 0.5NO, 1.OCL, 1.5CL, and CONT groups.
Abnormal function of CL was also observed in eleven MGAtreated cows, eight of these from groups treated with MGA
in the absence of CL. This is in agreement with previous
reports of shortened estrous cycles [4] and subfunctional
CL with reduced production of P4 [13] after treatment with
MGA. It has also been reported that MGA resulted in reduced size and weight of CL at Day 3 but not at Day 13 of
the subsequent estrous cycle [9].
In five cows, initiation of the estrous cycle was delayed
for more than 20 days post-treatment and concentrations of
P4 in plasma were greater than 1 ng/ml before the beginning of the next estrous cycle. Interestingly, we observed
the same phenomenon in a previous study [13]. These results suggest the possibility that the elevated concentrations
of LH associated with MGA administration may induce lu-
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teinization of ovarian follicles that could account for the
production of P4 observed in the present study [8]. Another
consideration that could explain this observation is that an
impaired or abnormal oocyte may reside in persistent ovarian follicles. This notion is supported by the observation
that removal of the oocyte from Graafian follicles in situ
promotes spontaneous luteinization and production of P4
by ovarian follicles in rabbits and rats [41-43]. It has also
been reported that the mouse oocyte inhibits production
of P4 by the cumulus oophorus in vitro [44]. Thus, prolonged periods of chronically elevated concentrations of E2
during and after treatment with MGA may cause damage to
the oocyte, which could promote spontaneous luteinization
and production of P4 by these ovarian follicles. These luteinized ovarian follicles may persist for longer periods,
thereby explaining the delayed initiation of the next estrous
cycle after treatment with MGA.
In summary, the doses of MGA used in the present study
did not suppress pulsatile secretion of LH as does endogenous P4 from the CL. Alterations in ovarian biosynthetic
processes are indicated by the increased secretion of E2
during and immediately after treatment with MGA. The increased frequency of LH pulses associated with MGA treatment in the absence of CL might result in the development
of persistent follicles and the ovulation of abnormal oocytes, accounting for the reduction in fertility observed in
cattle bred at the synchronized estrus. Treatment with MGA
possibly causes luteinization of ovarian follicles and induced abnormal luteal function. Therefore, data from the
present study indicate that if MGA is used alone, even at
greater doses than presently used for estrous synchronization, fertility at the synchronized estrus may be compromised.
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